Tacrolimus toxicity following topical treatment of perianal Crohn's disease: an admonitory anecdote.
Dermatology Centre, University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Manchester, UK. Electronic address: f.r.ali.01@cantab.net.
Faisal R
FR
Ali
Calum C
CC
Lyon
D000287:Administration, Topical; D001004:Anus Diseases / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D004244:Dizziness / Q000139:chemically induced; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D009325:Nausea / Q000139:chemically induced; D010292:Paresthesia / Q000139:chemically induced; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D055815:Young Adult
D007166:Immunosuppressive Agents; D016559:Tacrolimus